CD4 and B-cell non-Hodgkin lymphoma: In most cases, B cells serve as anticancer cells by inducing antigen-specific CD4+ and CD8+ T-cell responses as antigen-presenting cells, with the exception of B-cell lymphoma (Menon et al., 2021; Michaud et al., 2021).